Does EDOXABAN Cause Haemoptysis? 88 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Haemoptysis have been filed in association with EDOXABAN (SAVAYSA). This represents 1.1% of all adverse event reports for EDOXABAN.
88
Reports of Haemoptysis with EDOXABAN
1.1%
of all EDOXABAN reports
19
Deaths
59
Hospitalizations
How Dangerous Is Haemoptysis From EDOXABAN?
Of the 88 reports, 19 (21.6%) resulted in death, 59 (67.0%) required hospitalization, and 3 (3.4%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EDOXABAN. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does EDOXABAN Cause?
Anaemia (663)
Cerebral infarction (419)
Gastrointestinal haemorrhage (378)
Renal impairment (359)
Cerebrovascular accident (337)
Dyspnoea (331)
General physical health deterioration (315)
Haematuria (312)
Fall (298)
Cardiac failure (272)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
Which EDOXABAN Alternatives Have Lower Haemoptysis Risk?
EDOXABAN vs EDOXABAN TOSILATE
EDOXABAN vs EFALIZUMAB
EDOXABAN vs EFANESOCTOCOG ALFA
EDOXABAN vs EFAVIRENZ
EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL